Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
We have read the statements made by Kedem Pharmaceuticals Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Kedem Pharmaceuticals Inc. dated February 6, 2013. We agree with the statements concerning our Firm in such Form 8-K.
Yours very truly,
Leed Advisors Inc.